CONSOLIDATED STATEMENTS OF CASH FLOWS $ in Millions	12 Months Ended
	Mar. 31, 2021 USD ($)	Mar. 31, 2020 USD ($)	Mar. 31, 2019 USD ($)
OPERATING ACTIVITIES
Net income (loss)	$ (4,340)	$ 1,120	$ 255
Adjustments to reconcile to net cash provided by operating activities:
Depreciation	321	321	317
Amortization	566	601	632
Goodwill and other asset impairment charges	242	139	2,079
Equity earnings and charges from investment in Change Healthcare Joint Venture	0	1,084	194
Deferred taxes	(908)	(342)	189
Credits associated with last-in, first-out inventory method	(38)	(252)	(210)
Non-cash operating lease expense	334	366
(Gain) loss from sales of businesses and investments	(9)	33	(86)
Other non-cash items	188	615	52
Changes in assets and liabilities, net of acquisitions:
Receivables	1,145	(2,494)	(967)
Inventories	(2,276)	(376)	(368)
Drafts and accounts payable	1,267	3,952	1,976
Operating lease liabilities	(362)	(377)
Taxes	(166)	(8)	(95)
Litigation liabilities	8,067	0	0
Other	511	(8)	68
Net cash provided by operating activities	4,542	4,374	4,036
INVESTING ACTIVITIES
Payments for property, plant, and equipment	(451)	(362)	(426)
Capitalized software expenditures	(190)	(144)	(131)
Acquisitions, net of cash, cash equivalents, and restricted cash acquired	(35)	(133)	(905)
Proceeds from sales of businesses and investments, net	400	37	101
Other	(139)	23	(20)
Net cash used in investing activities	(415)	(579)	(1,381)
FINANCING ACTIVITIES
Proceeds from short-term borrowings	6,323	21,437	37,265
Repayments of short-term borrowings	(6,323)	(21,437)	(37,268)
Proceeds from issuances of long-term debt	500	0	1,099
Repayments of long-term debt	(1,040)	(298)	(1,112)
Common stock transactions:
Issuances	92	113	75
Share repurchases, including shares surrendered for tax withholding	(770)	(1,954)	(1,639)
Dividends paid	(276)	(294)	(292)
Other	(199)	(301)	(355)
Net cash used in financing activities	(1,693)	(2,734)	(2,227)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(61)	(19)	(119)
Net increase in cash, cash equivalents, and restricted cash	2,373	1,042	309
Cash, cash equivalents, and restricted cash at beginning of year	4,023	2,981	2,672
Cash, cash equivalents, and restricted cash at end of year	6,396	4,023	2,981
Less: Restricted cash at end of period included in Other Noncurrent Assets
Less: Restricted cash at end of year included in Prepaid expenses and other	(118)	(8)	0
Cash and cash equivalents at end of year	6,278	4,015	2,981
SUPPLEMENTAL CASH FLOW INFORMATION
Interest, net	220	235	383
Income taxes, net of refunds	$ 379	$ 368	$ 262